Growth Metrics

Bionano Genomics (BNGO) Total Liabilities (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Total Liabilities for 9 consecutive years, with $29.2 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 29.39% to $29.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $29.2 million through Dec 2025, down 29.39% year-over-year, with the annual reading at $29.2 million for FY2025, 29.39% down from the prior year.
  • Total Liabilities hit $29.2 million in Q4 2025 for Bionano Genomics, roughly flat from $29.3 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $118.2 million in Q4 2023 to a low of $10.9 million in Q2 2021.
  • Historically, Total Liabilities has averaged $44.3 million across 5 years, with a median of $39.2 million in 2021.
  • Biggest five-year swings in Total Liabilities: soared 236.45% in 2022 and later plummeted 65.08% in 2024.
  • Year by year, Total Liabilities stood at $40.0 million in 2021, then soared by 45.33% to $58.1 million in 2022, then surged by 103.51% to $118.2 million in 2023, then tumbled by 65.08% to $41.3 million in 2024, then fell by 29.39% to $29.2 million in 2025.
  • Business Quant data shows Total Liabilities for BNGO at $29.2 million in Q4 2025, $29.3 million in Q3 2025, and $30.6 million in Q2 2025.